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A sporadic case of Loeys-Dietz syndrome type I with 
two novel mutations of the TGFBR2 gene
A recently recognized connective tissue disorder, Loeys-Dietz syn-
drome (LDS) is a genetic aortic aneurysm syndrome caused by muta-
tions in the transforming growth factor-receptor type I or II gene 
(TGFBR1 or TGFBR2). They have distinctive phenotypic abnormalities 
including widely spaced eyes (hypertelorism), bifid uvula or cleft 
palate, and arterial tortuosity with aortic aneurysm or dissection 
throughout the arterial tree. LDS is characterized by aggressive and 
rapid progression of aortic aneurysm. Therefore, the patients with 
distinct phenotype, marked aortic dilatation and aneurysm at early 
age should be suspected to be affected by LDS and rapid TGFBR gene 
analysis should be done. We report one child diagnosed as LDS due to 
typical phenotypes and two novel missense mutations of the TGFBR2 
gene (c.1526G>T and c.1528A>T). 
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syndromes. 
We report a child who was diagnosed as LDS with specific, 
charac  terized phenotype and two novel gene missense mutations 
in TGFBR2 gene, and underwent surgical repair for aortic root 
aneurysm.
Case report
A 7-year-old girl was consulted from another department because 
of an abnormal electrocardiogram (ECG) pattern of severe left axis 
deviation and tall R in V5-6, and cardiomegaly (cardiothoracic 
ratio 0.62) in a chest X-ray. In physical examinations, she had 
ocular hypertelorism, bifid uvula (Fig. 1A) and high arched palate, 
strabismus, pectus excarvatum, arachnodactyly, calcaneus eversion 
and metatarsus adductus (Fig. 1B, C).
Introduction
Loeys-Dietz syndrome (LDS) is a recently recognized genetic aortic 
aneurysm syndrome characterized by the triad of hypertelorism, 
bifid uvula or cleft palate, and generalized arterial tortuosity with 
aneurysms and dissections throughout the arterial tree
1). LDS is 
associated with mutations in the transforming growth factor beta 
receptor type I (TGFBR1) and type II (TGFBR2) genes
1,2). These 
mutations cause increment of downstream TGFB signaling in the 
aortic media and subsequent overproduction of collagen, disarrayed 
elastic fiber and loss of elastin content in extracellular matrix
1-3). 
Therefore, patients with LDS usually show aggressive and rapid 
progression of aortic dilatation and regurgitation, and have a high risk 
of aortic dissection or rupture, even though the patients are young 
in age and had smaller aortic diameters than other aortic aneurysm Korean J Pediatr 2011;54(6):272-275 • DOI: 10.3345/kjp.2011.54.6.272    273
 Weight and height were in the 30th and >97th percentile, 
respectively.
In past history, she was born at term to a 30-year-old mother 
and a 30-year-old unrelated father. Her mother’s obstetric history 
was gravida 4, para 1, abortion 3 and was unremarkable. She was 
referred to our neonatal intensive care unit on day 1 of life for 
additional evaluation of a genetic syndrome in the setting of diffuse 
hypotonia and musculoskeletal abnormalities. All growth parameters 
including height, weight and head circumference were within normal 
limits. Family history was unremarkable. Investigations included 
chromosomal study, skeletal imaging, ultrasonogram of the head, and 
echocardiography. Although she had abnormal skeletal morphology, 
her chromosome was normal. She had no intracranial abnormalities. 
A small patent ductus arteriosus without aneurysm and a small atrial 
septal were defected on echocardiography. 
She underwent serial orthopedic surgical intervention for correction 
for lower-extremity abnormalities at neonatal and childhood period 
and had done regular follow-up at the orthopedic department. The 
patient was subsequently lost to the cardiology department follow-
up until cardiology consult was performed because of cardiomegaly 
and abnormal ECG findings for ophthalmologic intervention due to 
strabismus. 
When she was consulted for abnormal ECG, subsequent echo-
cardiography was performed and revealed marked dilated aortic 
annulus and root
4), which measured 23 to 24 mm and 33 to 35 mm, 
respectively (Z-value >2, body surface area =0.83), with grade II aortic 
regurgitation, dilated pulmonary annulus (24 to 25 mm, Z-value 
>2), and small cone shaped patent ductus arteriosus. Computed 
tomography (CT) angiography showed arterial tortuosity at the 
common carotid artery (Fig. 2). 
Based on above findings, the suspicion of LDS rather than Marfan 
syndrome (MFS) was raised because she had all of the typical triad 
of LDS, such as facial abnormalities (hypertelorism and bifid uvula), 
markedly dilated aortic annulus and root in spite of young age and 
arterial tortuosity of the neck vessels. Moreover she did not have 
ectopia lentis or myopia which is the frequent findings in MFS. 
To confirm our clinical diagnosis of LDS, we performed molecular 
genetic testing of the TGFBR1 and TGFBR2 genes. Informed 
consent of the parents was obtained prior to genetic testing.
All coding exons and flanking intron regions of the TGFBR1 and 
TGFBR2 genes were amplified and sequenced using primer sets 
designed in our laboratory. In TGFBR1 gene, we could not detect 
any variations, whereas we identified one synonymous, one intronic 
and two missense variations in the TGFBR2 gene (Table 1). Of 
these, one intronic (c.263+7A>G, rs1155705) and one synonymous 
(c.1167C>T, rs2228048) variations were inherited from one of 
parents and known-polymorphisms listed in the single nucleotide 
polymorphism database (dbSNP; http://www.ncbi.nlm.nih.gov/
projects/SNP/). However, the two heterozygous missense variations 
(c.1526G>T c.1528A>T) were novel variations which have not been 
described in any previous literatures. These two missense variations 
were not detected in the proband’s parents suggesting as de novo 
(Fig. 3). These variations are located in exon 7 and are included in the 
highly conserved serine/threonine kinase domain XI of TGFBR2. 
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Fig. 1. The patient had (A) bifid uvula (B,C) metatarsus adductus.
Fig. 2. Computed tomography angiography showed arterial tortuosity at 
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Furthermore, when we checked the influence of these variations 
to the function of protein using sorting intolerant from tolerant 
algorithm, both of those variations are expected to affect protein 
function. When we used the polymorphism phenotyping (PolyPhen) 
algorithm, Gly509Val was expected as ‘probably damaging variation’ 
and Ile510Phe was expected as benign one. 
Medication of angiotensin receptor II antagonist (losartan, 0.5 mg/
kg/day) was started and prophylactic surgical repair for aortic root 
aneurysm such as valve sparing root replacement was performed. 
So far, surgical intervention was successful, she has had a medical 
checkup at regular intervals with losartan medication and CT 
angiography every year.
Discussion
Loeys et al.
2) first reported six families who had phenotype charac-
terized by typical cardiovascular (generalized arterial tortuosity and 
aneurysms with dissection throughout the arterial tree), craniofacial 
(hypertelorism, bifid uvula and/or cleft palate), and skeletal (pectus 
excarvatum, dolichostenomelia, arachnodactyly and metatarsus 
adductus) manifestations, and heterozygous mutations in the genes 
encoding TGFBR I or II. They described this phenotype as LDS, a 
new aortic aneurysm syndrome. So far, more than 80 LDS patients 
including some pediatric patients have been described in previous 
papers, and many TGFBR1 or TGFBR2 gene mutations have been 
also reported in those patients
2,5-7). 
TGFBR2 gene, which is located chromosome 3p22.5, consists of 
seven exons and six introns, and encodes the human TGFBR II
8). 
This receptor regulates cellular proliferation, differentiation, motility, 
organization, apoptosis, and formation of extracellular matrix, 
especially in the cardiovascular system
9,10). Mutations of TGFBR2 
gene are associated with increased downstream TGFB signaling 
in the aortic media, overproduction and deposition  of collagen, 
organization of elastic fiber and loss of elastin content in extracellular 
matrix
1-3). Excessive collagen deposition results in weakness of aortic 
vascular bed, dilatation and dissection of the aorta. 
The LDS phenotype may resemble that of the MFS. MFS is 
characterized by skeletal, ocular, cardiovascular, pulmonary, skin 
findings, and dural ectasia. Among of these findings for MFS, specific 
ocular finding, bilateral ectopia lentis occurs in about 40 to 56% of 
patients with MFS
11) and does not occur in LDS
1). In comparison 
to MFS, LDS patients show typical characteristics such as facial 
dysmorphology (hypertelorism, bifid uvula and/or cleft palate), aortic 
root aneurysm, aneurysm of other vessels and widespread arterial 
tortuosity
1,2,12). If the patient has typical characteristics for LDS and 
does not have ectopia lentis, the patient can be diagnosed with LDS 
and gene testing for LDS should be performed.
In respect to specific genotype, LDS patients show TGFBR1 or 
TGFBR2 gene mutations but do not show mutations in the gene 
encoding fibrillin-1 (FBN1). On the other hand, most of MFS 
patients show mutations in the gene encoding FBN1 although some 
of MFS patients have been reported to have TGFBR mutations 
without FBN1 mutations
5). LDS patients have arterial tortuosity 
and aneurysms throughout the arterial tree, whereas the main target 
vessel in MFS is the ascending aorta and aortic root
1,2,12). Therefore, 
the initial evaluation of patients with a presentation similar to that 
of MFS requires a multi-disciplinary approach including clinical 
genetics, cardiology, ophthalmology and radiology. 
The most important finding of LDS is the aggressive and rapid 
progression of aortic pathology even though the patients are young 
Table 1. Genetic Variations Identified in the TGFBR2 Gene in the Patient
Nucleotide change Amino acid change dbSNP ID Exon/intron Type Inheritance
c.263+7A>G - rs1155705 Intron2 Hetero Inherited
c.1167C>T Asn389Asn rs2228048 Exon4 Hetero Inherited
c.1526G>T Gly509Val Exon7 Hetero De novo
c.1528A>T Ile510Phe Exon7 Hetero De novo
dbSNP, single nucleotide polymorphism database.
Fig. 3. DNA chromatograms from the patient and parents are shown. In 
patient, G to T and A to T transitions are shown at nucleotide position 
1526 and 1528, respectively. These variations substituted a Gly for a Val 
and an Ile for a Phe at codon 509 and 510, repectively. In parents, any 
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in age and shorter median survival due to occurrence of dissections 
at smaller diameters than in other connective-tissue disorders
1,13). 
The median survival was 37 years among patients with LDS
1), 48 
years among patients with vascular Ehlers-Danlos syndrome
14) and 
70 years among patients with MFS who underwent treatment
15). 
In previous report, mean age of operation was 9.2+5.7 years (range, 
0.5 to 17 years) in pediatric patients undergoing aortic surgery
13). 
Among 14 pediatric patients, 3 patients aged younger than 10 years 
had fatal aortic dissection and intracerebral hemorrhage, and these 
findings occurred in patients who had a smaller aortic root diameter 
than in MFS patients
13). Our patient also showed marked aortic root 
dilatation and progressive aortic regurgitation when she was 7-year-
old, so we considered early surgical intervention.
In conclusion, patients with distinct phenotypic characteristics, 
marked aortic dilatation and aneurysm at early age should be 
suspected to be affected by LDS and could benefit from rapid 
TGFBR1 or TGFBR2 gene analysis. Early genetic diagnosis is the 
essential tool to make adequate management for LDS patients. 
If clinical diagnosis is confirmed by molecular genetic testing of 
the TGFBR genes, according to guideline
13), medical checkup 
and clinical assessments using echocardiography, CT or magnetic 
resonance imaging angiography at regular intervals, and early, 
prophylactic surgical intervention of abnormal aortic dilation and 
aneurysm such as valve sparing root replacement, must be done to 
prevent future vascular events.
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